Lithium Americas jumps as J.P. Morgan upgrades on improved long-term lithium outlook (LAC:NYSE)September 9, 2026
Share Facebook Twitter LinkedIn Pinterest Email Urogen pharma outlines $1B revenue potential for UGN-102 with June 2025 launch target
Lithium Americas jumps as J.P. Morgan upgrades on improved long-term lithium outlook (LAC:NYSE)September 9, 2026
SailPoint outlines FY2029 targets including at least $2.1B ARR amid agentic AI push (NASDAQ:SAIL)September 9, 2026